arrow
J

John T. Nelson

Novartis
H指数:12
被引数:606

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-d]pyrimidine RET Inhibitors
2021-11-065
OA
Structure-Based Design of Selective LONP1 Inhibitors for Probing In Vitro Biology
2021-04-067
PREAI
Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma

吡唑并 [1,5-a] 嘧啶RET激酶抑制剂治疗肺腺癌的疗效和耐受性

2020-02-1218
OAAI
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis

Ndufexor (LMB763),一种用于治疗非酒精性脂肪性肝炎的新型FXR调节剂

2020-01-1585
OAAI
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases
2017-10-0439
OAAI